NCT05300048 2025-10-06Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA MutationsFaeth TherapeuticsPhase 1 Completed34 enrolled